BVA-200 vs BVA-100 Validation Study

Clinical trial NCT06227819 · COMPLETED

Trial details

NCT number: NCT06227819
Sponsor: Daxor Corporation
Status: COMPLETED
Study type: OBSERVATIONAL

Heart Failure High Blood Pressure High Cholesterol Anemia Diabetes Thyroid Diseases Kidney Diseases Clotting Disorder Trauma Other Disease

Start date: 2023-05-23
Primary completion: 2023-11-30
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.